BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zeidler JD, Hogan KA, Agorrody G, Peclat TR, Kashyap S, Kanamori KS, Gomez LS, Mazdeh DZ, Warner GM, Thompson KL, Chini CCS, Chini EN. The CD38 glycohydrolase and the NAD sink: implications for pathological conditions. Am J Physiol Cell Physiol 2022;322:C521-45. [PMID: 35138178 DOI: 10.1152/ajpcell.00451.2021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Hogan KA, Zeidler JD, Beasley HK, Alsaadi AI, Alshaheeb AA, Chang Y, Tian H, Hinton AO, Mcreynolds MR. Using mass spectrometry imaging to visualize age-related subcellular disruption. Front Mol Biosci 2023;10. [DOI: 10.3389/fmolb.2023.906606] [Reference Citation Analysis]
2 Feuz MB, Meyer-Ficca ML, Meyer RG. Beyond Pellagra-Research Models and Strategies Addressing the Enduring Clinical Relevance of NAD Deficiency in Aging and Disease. Cells 2023;12. [PMID: 36766842 DOI: 10.3390/cells12030500] [Reference Citation Analysis]
3 Rai R. Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases. Purinergic System 2022. [DOI: 10.5772/intechopen.104978] [Reference Citation Analysis]
4 Cercillieux A, Ciarlo E, Canto C. Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations. Cell Mol Life Sci 2022;79:463. [PMID: 35918544 DOI: 10.1007/s00018-022-04499-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sulaymonov SA, Abdullayev SV. APIGENIN TIBBIY QO'SHIMCHALAR ASOSI. ЖурХимТовНарМед 2022;1:137-151. [DOI: 10.55475/jcgtm/vol1.iss3.2022.58] [Reference Citation Analysis]
6 Wu M, Liu F, Yan L, Huang R, Hu R, Zhu J, Li S, Long C. MiR-145-5p restrains chondrogenic differentiation of synovium-derived mesenchymal stem cells by suppressing TLR4. Nucleosides Nucleotides Nucleic Acids 2022;41:625-42. [PMID: 35403567 DOI: 10.1080/15257770.2022.2057535] [Reference Citation Analysis]
7 Canto C. NAD+ Precursors: A Questionable Redundancy. Metabolites 2022;12:630. [PMID: 35888754 DOI: 10.3390/metabo12070630] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Meyer-Ficca ML, Zwerdling AE, Swanson CA, Tucker AG, Lopez SA, Wandersee MK, Warner GM, Thompson KL, Chini CCS, Chen H, Chini EN, Meyer RG. Low NAD(+) Levels Are Associated With a Decline of Spermatogenesis in Transgenic ANDY and Aging Mice. Front Endocrinol (Lausanne) 2022;13:896356. [PMID: 35600581 DOI: 10.3389/fendo.2022.896356] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Banerjee P, Olmsted-Davis EA, Deswal A, Nguyen MT, Koutroumpakis E, Palaskas NL, Lin SH, Kotla S, Reyes-Gibby C, Yeung SJ, Yusuf SW, Yoshimoto M, Kobayashi M, Yu B, Schadler K, Herrmann J, Cooke JP, Jain A, Chini E, Le NT, Abe JI. Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications. J Cardiovasc Aging 2022;2:28. [PMID: 35801078 DOI: 10.20517/jca.2022.13] [Reference Citation Analysis]